Delayed bone regeneration is linked to chronic inflammation in murine muscular dystrophy

Journal of Bone and Mineral Research

Volumn 29, Issue 2, 2014, Pages 304-315

  Abou Khalil, Rana ^a   Yang, Frank ^b   Mortreux, Marie ^b   Lieu, Shirley ^b   Yu, Yan Yiu ^b   Wurmser, Maud ^b   Pereira, Catia ^a   Relaix, Frédéric ^c   Miclau, Theodore ^b   Marcucio, Ralph S ^b   Colnot, Céline ^a  

^a INSERM   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

ANGIOGENESIS; BONE; CARTILAGE; CHRONIC INFLAMMATION; MACROPHAGE; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; OSTEOCLASTOGENESIS; REGENERATION

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLONY STIMULATING FACTOR RECEPTOR; OSTEOCALCIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE; BONE DEVELOPMENT; BONE MASS; BONE MATRIX; BONE REGENERATION; BONE REMODELING; CALLUS; CARTILAGE; CARTILAGE CELL; CARTILAGE MATRIX; CHONDROGENESIS; CHONDROLYSIS; CHRONIC INFLAMMATION; COMPARATIVE STUDY; CONTROLLED STUDY; FRACTURE HEALING; HEMATOPOIETIC TISSUE; MACROPHAGE; MALE; MONOCYTE; MOUSE; MUSCLE ATROPHY; MUSCLE INJURY; MUSCULAR DYSTROPHY; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; TIBIA FRACTURE; VASCULARIZATION;

ANGIOGENESIS; BONE; CARTILAGE; CHRONIC INFLAMMATION; MACROPHAGE; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; OSTEOCLASTOGENESIS; REGENERATION;

ANIMALS; BONE REGENERATION; CARTILAGE; CHRONIC DISEASE; HUMANS; INFLAMMATION; MICE; MICE, INBRED MDX; MONOCYTES; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; OSTEOCLASTS;

EID: 84892744253     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2038     Document Type: Article

References (62)

1. Sudkamp NP, Haas NP, Sinnig M, Sottmann G, Tscherne H,. [Incidence of pseudarthroses in open fractures: analysis of 948 open fractures]. Aktuelle Traumatol. 1993; 23 (2): 59-67.
2. Yazar S, Lin CH, Lin YT, Ulusal AE, Wei FC,. Outcome comparison between free muscle and free fasciocutaneous flaps for reconstruction of distal third and ankle traumatic open tibial fractures. Plast Reconstr Surg. 2006; 117 (7): 2468-75; discussion 2476-7.
3. Evans KD, Oberbauer AM,. Alendronate inhibits VEGF expression in growth plate chondrocytes by acting on the mevalonate pathway. Open Orthop J. 2009; 3: 83-8.
4. Cairns DM, Uchimura T, Kwon H, et al. Muscle cells enhance resistance to pro-inflammatory cytokine-induced cartilage destruction. Biochem Biophys Res Commun. 2010; 392 (1): 22-8.
5. Einhorn TA,. The cell and molecular biology of fracture healing. Clin Orthop Relat Res. 1998; 46 (355 Suppl): S7-21.
6. Ai-Aql ZS, Alagl AS, Graves DT, Gerstenfeld LC, Einhorn TA,. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res. 2008; 87 (2): 107-18.
7. Einhorn TA, Majeska RJ, Rush EB, Levine PM, Horowitz MC,. The expression of cytokine activity by fracture callus. J Bone Miner Res. 1995; 10 (8): 1272-81.
8. Phillips AM,. Overview of the fracture healing cascade. Injury. 2005; 36 (Suppl 3): S5-7.
9. Tsiridis E, Upadhyay N, Giannoudis P,. Molecular aspects of fracture healing: which are the important molecules ? Injury. 2007; 38 (Suppl 1): S11-25.
10. Dimitriou R, Tsiridis E, Giannoudis PV,. Current concepts of molecular aspects of bone healing. Injury. 2005; 36 (12): 1392-404.
11. Hamrick MW, McNeil PL, Patterson SL,. Role of muscle-derived growth factors in bone formation. J Musculoskelet Neuronal Interact. 2010; 10 (1): 64-70.
12. Gerstenfeld LC, Cho TJ, Kon T, et al. Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. J Bone Miner Res. 2003; 18 (9): 1584-92.
13. Thompson Z, Miclau T, Hu D, Helms JA,. A model for intramembranous ossification during fracture healing. J Orthop Res. 2002; 20 (5): 1091-8.
14. Colnot C, Thompson Z, Miclau T, Werb Z, Helms JA,. Altered fracture repair in the absence of MMP9. Development. 2003; 130 (17): 4123-33.
15. Palomares KT, Gleason RE, Mason ZD, et al. Mechanical stimulation alters tissue differentiation and molecular expression during bone healing. J Orthop Res. 2009; 27 (9): 1123-32.
16. Lynch JR, Taitsman LA, Barei DP, Nork SE,. Femoral nonunion: risk factors and treatment options. J Am Acad Orthop Surg. 2008; 16 (2): 88-97.
17. Morgan JE, Zammit PS,. Direct effects of the pathogenic mutation on satellite cell function in muscular dystrophy. Exp Cell Res. 2010; 316 (18): 3100-8.
18. Reimann J, Irintchev A, Wernig A,. Regenerative capacity and the number of satellite cells in soleus muscles of normal and mdx mice. Neuromuscul Disord. 2000; 10 (4-5): 276-82.
19. Partridge T,. Pathophysiology of muscular dystrophy. Br J Hosp Med. 1993; 49 (1): 26-36.
20. Rufo A, Del Fattore A, Capulli M, et al. Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans. J Bone Miner Res. 2011; 26 (8): 1891-03.
21. Nakagaki WR, Bertran CA, Matsumura CY, Santo-Neto H, Camilli JA,. Mechanical, biochemical and morphometric alterations in the femur of mdx mice. Bone. 2011; 48 (2): 372-9.
22. Novotny SA, Warren GL, Lin AS, Guldberg RE, Baltgalvis KA, Lowe DA,. Bone is functionally impaired in dystrophic mice but less so than skeletal muscle. Neuromuscul Disord. 2011; 21 (3): 183-93.
23. Philippe V, Pruna L, Abdel Fattah M, Pascal V, Kaminsky P,. Decreased bone mineral density in adult patients with muscular dystrophy. Joint Bone Spine. 2011; 78 (6): 651-2.
24. McDonald DG, Kinali M, Gallagher AC, et al. Fracture prevalence in Duchenne muscular dystrophy. Dev Med Child Neurol. 2002; 44 (10): 695-8.
25. Bianchi ML, Morandi L, Andreucci E, Vai S, Frasunkiewicz J, Cottafava R,. Low bone density and bone metabolism alterations in Duchenne muscular dystrophy: response to calcium and vitamin D treatment. Osteoporos Int. 2011; 22 (2): 529-39.
26. Bianchi ML, Mazzanti A, Galbiati E, et al. Bone mineral density and bone metabolism in Duchenne muscular dystrophy. Osteoporos Int. 2003; 14 (9): 761-7.
27. Larson CM, Henderson RC,. Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop. 2000; 20 (1): 71-4.
28. Tanabe Y, Esaki K, Nomura T,. Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol. 1986; 69 (1-2): 91-5.
29. Porter JD, Khanna S, Kaminski HJ, et al. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet. 2002; 11 (3): 263-72.
30. Cullen MJ, Jaros E,. Ultrastructure of the skeletal muscle in the X chromosome-linked dystrophic (mdx) mouse. Comparison with Duchenne muscular dystrophy. Acta Neuropathol. 1988; 77 (1): 69-81.
31. Partridge T,. Animal models of muscular dystrophy-what can they teach us ? Neuropathol Appl Neurobiol. 1991; 17 (5): 353-63.
32. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, Barnard PJ,. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science. 1989; 244 (4912): 1578-80.
33. Abou-Khalil R, Le Grand F, Pallafacchina G, et al. Autocrine and paracrine angiopoietin 1/Tie-2 signaling promotes muscle satellite cell self-renewal. Cell Stem Cell. 2009; 5 (3): 298-309.
34. Lu C, Miclau T, Hu D, et al. Cellular basis for age-related changes in fracture repair. J Orthop Res. 2005; 23 (6): 1300-7.
35. Lu C, Hansen E, Sapozhnikova A, Hu D, Miclau T, Marcucio RS,. Effect of age on vascularization during fracture repair. J Orthop Res. 2008; 26 (10): 1384-9.
36. Lu C, Saless N, Hu D, et al. Mechanical stability affects angiogenesis during early fracture healing. J Orthop Trauma. 2011; 25 (8): 494-9.
37. Lu C, Xing Z, Wang X, Mao J, Marcucio RS, Miclau T,. Anti-inflammatory treatment increases angiogenesis during early fracture healing. Arch Orthop Trauma Surg. 2012; 132 (8): 1205-13.
38. Wang X, Yu YY, Lieu S, et al. MMP9 regulates the cellular response to inflammation after skeletal injury. Bone. 2013; 52 (1): 111-9.
39. Xing Z, Lu C, Hu D, et al. Multiple roles for CCR2 during fracture healing. Dis Model Mech. 2010; 3 (7-8): 451-8.
40. Maes C, Coenegrachts L, Stockmans I, et al. Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair. J Clin Invest. 2006; 116 (5): 1230-42.
41. Boyle WJ, Simonet WS, Lacey DL,. Osteoclast differentiation and activation. Nature. 2003; 423 (6937): 337-42.
42. Coulton GR, Morgan JE, Partridge TA, Sloper JC,. The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol. 1988; 14 (1): 53-70.
43. Nam D, Mau E, Wang Y, Wright D, Silkstone D, Whetstone H, et al. T-lymphocytes enable osteoblast maturation via IL-17F during the early phase of fracture repair. PLoS One. 2012; 7 (6): e40044. Epub 2012/07/07.
44. Claes L, Recknagel S, Ignatius A,. Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol. 2012; 8 (3): 133-43.
45. Chazaud B, Brigitte M, Yacoub-Youssef H, et al. Dual and beneficial roles of macrophages during skeletal muscle regeneration. Exerc Sport Sci Rev. 2009; 37 (1): 18-22.
46. Prada CE, Jousma E, Rizvi TA, Wu J, Dunn RS, Mayes DA, et al. Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition. Acta Neuropathol. 2013; 125 (1): 159-68.
47. Leng Y, Zheng Z, Zhou C, Zhang C, Shi X, Zhang W,. A comparative study of bone marrow mesenchymal stem cell functionality in C57BL and mdx mice. Neurosci Lett. 2012; 523 (2): 139-44.
48. Straino S, Germani A, Di Carlo A, et al. Enhanced arteriogenesis and wound repair in dystrophin-deficient mdx mice. Circulation. 2004; 110 (21): 3341-8.
49. Ito K, Kimura S, Ozasa S, et al. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice. Hum Mol Genet. 2006; 15 (14): 2266-75.
50. Grcevic D, Pejda S, Matthews BG, et al. In vivo fate mapping identifies mesenchymal progenitor cells. Stem Cells. 2012; 30 (2): 187-96.
51. Acharyya S, Villalta SA, Bakkar N, et al. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest. 2007; 117 (4): 889-901.
52. Villalta SA, Nguyen HX, Deng B, Gotoh T, Tidball JG,. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet. 2009; 18 (3): 482-96.
53. Hamrick MW, Della Fera MA, Choi YH, Hartzell D, Pennington C, Baile CA,. Injections of leptin into rat ventromedial hypothalamus increase adipocyte apoptosis in peripheral fat and in bone marrow. Cell Tissue Res. 2007; 327 (1): 133-41.
54. Alexander KA, Chang MK, Maylin ER, et al. Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J Bone Miner Res. 2011; 26 (7): 1517-32.
55. Claes L, Ignatius A, Lechner R, et al. The effect of both a thoracic trauma and a soft-tissue trauma on fracture healing in a rat model. Acta Orthop. 2011; 82 (2): 223-7.
56. Cho TJ, Kim JA, Chung CY, et al. Expression and role of interleukin-6 in distraction osteogenesis. Calcif Tissue Int. 2007; 80 (3): 192-200.
57. Wada T, Nakashima T, Hiroshi N, Penninger JM,. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med. 2006; 12 (1): 17-25.
58. Serrano AL, Mann CJ, Vidal B, Ardite E, Perdiguero E, Munoz-Canoves P,. Cellular and molecular mechanisms regulating fibrosis in skeletal muscle repair and disease. Curr Top Dev Biol. 2011; 96: 167-201.
59. Fenichel GM, Florence JM, Pestronk A, et al. Long-term benefit from prednisone therapy in Duchenne muscular dystrophy. Neurology. 1991; 41 (12): 1874-7.
60. De Larichaudy J, Zufferli A, Serra F, et al. TNF-alpha- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism. Skelet Muscle. 2012; 2 (1): 2.
61. D'Angelo MG, Gandossini S, Martinelli Boneschi F, et al. Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: evidence from a safety study with pilot efficacy measures in adult dystrophic patients. Pharmacol Res. 2012; 65 (4): 472-9.
62. Abdul-Hadi O, Parvizi J, Austin MS, Viscusi E, Einhorn T,. Nonsteroidal anti-inflammatory drugs in orthopaedics. J Bone Joint Surg Am. 2009; 91 (8): 2020-7.